Biomedical Engineering Reference
In-Depth Information
3.3 Conclusions
Several production techniques are available and have been discussed in this chap-
ter. The particle characteristics of the lipid nanoparticles is expected to be greatly
influenced by the choice of method employed in its production (see next chapter).
The choice of method also depends on the composition of the lipid nanoparticle
formulation. Table 3.1 outlines the various techniques discussed here with the pos-
sible mechanism involved in particle formation. Each of the methods developed to
date have their own advantages and disadvantages (also discussed in Table 3.1 ).
A novel method developed by the authors is a rapid technique with many advan-
tages, and few disadvantages, but may face limitations in scalability and is not yet
fully tested. Based on literature, it can thus be concluded that no method is perfect,
and choice of method will depend on availability of equipment, composition of the
lipid formulation and desired property outcomes.
References
An Z, Tang W, Hawker C, Stucky G (2006) One-step microwave preparation of well-defined and
functionalized polymeric nanoparticles. J Am Chem Soc 128(47):15054-15055
Battaglia L, Trotta M, Gallarate M, Carlotti M, Zara G, Bargoni A (2007) Solid lipid nanoparti-
cles formed by solvent-in-water emulsion-diffusion technique: development and influence on
insulin stability. J Microencapsul 24(7):672-684
Battaglia L, Gallarate M, Cavalli R, Trotta M (2010) Solid lipid nanoparticles produced through
a coacervation method. J Microencapsul 27(1):78-85
Battaglia L, Serpe L, Muntoni E, Zara G, Trotta M, Gallarate M (2011) Methotrexate-loaded
SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics
and biodistribution. Nanomedicine 6(9):1561-1573
Batzri S, Korn E (1973) Single bilayer liposomes prepared without sonication. BBA-
Biomembranes. 298(4):1015-1019
Bergese P, Colombo I, Gervasoni D, Depero L (2003) Microwave generated nanocomposites for
making insoluble drugs soluble. Mat Sci Eng C—Bio S 23(6-8):791-795
Bianco M, Gallarate M, Trotta M, Battaglia L (2010) Amphotericin B loaded SLN prepared with
the coacervation technique. J Drug Deliv Sci Tec 20(3):187-191
Blasi P, Schoubben A, Romano G, Giovagnoli S, Di Michele A, Ricci M (2013a) Lipid nanopar-
ticles for brain targeting II. Technological characterization. Colloid Surface B 110:130-137
Blasi P, Schoubben A, Traina G, Manfroni G, Barberini L, Alberti P et al (2013b) Lipid nan-
oparticles for brain targeting III. Long-term stability and in vivo toxicity. Int J Pharm
454(1):316-323
Bunjes H, Westesen K, Koch M (1996) Crystallization tendency and polymorphic transitions in
triglyceride nanoparticles. Int J Pharm 129(1):159-173
Byrappa K, Ohara S, Adschiri T (2008) Nanoparticles synthesis using supercritical fluid technol-
ogy—towards biomedical applications. Adv Drug Deliver Rev 60(3):299-327
Charcosset C, Fessi H (2005) Preparation of nanoparticles with a membrane contactor. J
Membrane Sci. 266(1-2):115-120
Charcosset C, Limayem I, Fessi H (2004) The membrane emulsification process—a review. J
Chem Technol Biot 79(3):209-218
Charcosset C, El-Harati A, Fessi H (2005) Preparation of solid lipid nanoparticles using a mem-
brane contactor. J Control Release. 108(1):112-120
Search WWH ::




Custom Search